Fixed-Duration First-Line Therapy for Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) in Canada: A Canadian Expert Clinical Framework. (2026). Actualité hématologique Au Canada, 5(s03), 2-16. https://doi.org/10.58931/cht.2026.5s0394